CAS: 203245-17-4; 1,2,3-Trifluoro-5-Methoxybenzene

该化合物是一种芳香化合物,其特点是存在三个氟原子和一个附于苯环的甲氧(-OCH3)组,三氟甲基组对其化学特性有重大影响,提高了其电子密度,使其与非氟类比相比更具反应性.由于苯环的芳香性质,这种化合物一般具有高度稳定性,而氟代成分可产生独特的溶性特征,并改变其与生物系统的互动.甲基氧组有助于其总体极度,并可能影响其在电子代用芳香反应中的再活动. 1,3-三氟-5-氟氧苯因其独特性质,可在各个领域找到应用,包括药品,农业化学品和材料科学.应当参考安全数据,以便处理和使用,因为氟化化合物可构成特定的健康和环境风险.

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-7615634-B2
    优先权日:2003-02-10
    标题:4-aminopyrimidine-5-one derivatives
    发明人:BARTKOVITZ DAVID JOSEPH; CHU XIN-JIE; DING QINGJIE; JIANG NAN; LOVEY ALLEN JOHN; MOLITERNI JOHN ANTHONY; MULLIN JR JOHN GUILFOYLE; VU BINH THANH; WOVKULICH PETER MICHAEL
    权利人:HOFFMANN LA ROCHE
    摘要:Novel intermediate compounds are disclosed. These compounds are useful in the synthesis of 4-aminopyrimidine-5-one derivatives that inhibit cyclin-dependent kinases, in particular cyclin-dependent kinase 4 (Cdk4). The 4-aminopyrimidine-5-one derivatives and their pharmaceutically acceptable salts have antiproliferative activity and are useful in the treatment or control of cancer, in particular solid tumors.

    专利号:CA-3170288-A1
    优先权日:2020-03-04
    标题:Synthesis of novel ep4 antagonist and use in cancer and inflammation

    专利号:EP-4116291-A1
    优先权日:2020-03-04
    标题:Synthesis of novel ep4 antagonist and use in cancers and inflammations

    专利号:US-2023125494-A1
    优先权日:2020-03-04
    标题 :Synthesis of novel ep4 antagonist and use in cancer and inflammation

    专利号:CN-113354585-A
    优先权日:2020-03-04
    标 题:Synthesis of novel EP4 antagonists and their use in cancer and inflammation

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知